bioAffinity Technologies
BIAFW
5 hedge funds and large institutions have $137K invested in bioAffinity Technologies in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
61% more capital invested
Capital invested by funds: $85K → $137K (+$52K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.04% less ownership
Funds ownership: 3.38% → 3.34% (-0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$4.12K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$88 |
| 3 |
CS
Clear Street
New York
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $105K | – | -1 | -0% |
|
|
CS
2
Clear Street
New York
| $13K | +$31 | +100 | +0.4% |
|
|
3
Citadel Advisors
Miami,
Florida
| $10.3K | +$4.12K | +13,304 | +87% |
|
|
WAM
4
Warberg Asset Management
Winnetka,
Illinois
| $8.9K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $60 | +$88 | +285 | New |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4.22K | -14,077 | Closed |
|
BIAFW Hedge Fund Activity: Q2 2023 in Review
5 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q2 2023, worth a combined $137K — up 61% from $85K a quarter earlier.
Fund positioning in BIAFW was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $4.12K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $4.22K sold.
- 5 institutional investors held bioAffinity Technologies (BIAFW) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $137K of bioAffinity Technologies stock for Q2 2023, up 61% quarter-over-quarter.
- 1 fund opened new bioAffinity Technologies positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest bioAffinity Technologies buyer in Q2 2023 was Citadel Advisors, an estimated $4.12K added.
- The largest bioAffinity Technologies seller in Q2 2023 was Susquehanna International Group, an estimated $4.22K sold.
Based on aggregated 13F filings for Q2 2023.